Proposed LCD DL34356: Erythropoiesis Stimulating Agents (ESA) — CGS
Policy LCD-DL34356 · Oncology
Review proposed LCD on ESAs before July 4, 2026.
Code intelligence
Q5105 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code Q5105.
Signal breakdown
4 shown · 4 total in platform
Risk: Critical
1
Critical
25%
1
High
25%
1
Routine
25%
1
Low
25%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Critical
Proposed LCD DL40334: Erythropoiesis Stimulating Agents — NGS
Policy LCD-DL40334 · Hematology
New LCD could affect reimbursement for anemia treatments.
LCD L34356: Erythropoiesis Stimulating Agents (ESA) — CGS
Policy LCD-L34356 · Hematology
New LCD for ESAs effective 03/05/2026.
LCD L40334: Erythropoiesis Stimulating Agents — NGS
Policy LCD-L40334 · ESRD
NGS ESA LCD goes live 7/15/2026 — review Hgb thresholds & docs now.
Audit documentation
Building an audit file that includes Q5105?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription